Assessing Primary Aldosteronism Screening Implementation and Interpretation in an Outpatient Internal Medicine Clinic: A Cohort Study
AACE Endocrinology and Diabetes · 2026-05 · 13 (3) · 527-532
DOI: 10.1016/j.aed.2026.01.017 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift AACE Endocrinology and Diabetes, 2026-05. Verfasst von Rachel B Allen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background/Objective: Primary aldosteronism (PA) is associated with increased cardiovascular risk and accounts for up to 30% of resistant hypertension cases, but less than 2% of true PA cases are diagnosed. The aldosterone-to-renin ratio (ARR) is the most common screening tool but is often misinterpreted due to failure to assess aldosterone and renin separately. Appropriate screening should be conducted off mineralocorticoid antagonists and serum potassium should be within normal limits on the day of testing. The aim of this study was to determine rates of appropriate PA screening and management in primary care.
Methods
Adults newly established between 2021 and 2024 with indications for PA screening including resistant hypertension, hypertension on ≥4 medications or 3 medications with blood pressure > 130/80 mmHg, or hypertension with atrial fibrillation, adrenal adenoma, or hypokalemia were included. We assessed whether patients underwent renin and aldosterone testing, if testing occurred under appropriate conditions, and whether results were interpreted correctly.
Results
A total of 312 patients were indicated for PA screening primarily due to being on 3 antihypertensives with uncontrolled blood pressure (35.3%) or ≥4 antihypertensives (42.9%). Twelve patients (3.8%) were screened for PA, and 5 (41.7%) of those patients were screened appropriately. All screenings were interpreted as negative, yet 4 patients had true positive results. This study was limited to new patient encounters within a single internal medicine clinic and only followed patients for up to 12 months.
Conclusion
PA remains underdiagnosed and mismanaged in primary care. Findings highlight the need for better provider education, awareness, and standardized protocols to improve detection and treatment for PA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina.
- University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina.
- Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Zitieren
APA
Allen, R. B., Hui, T., Tungate Lopez, S., Komé, A. M., Yang, A., Zink, L., & Espinosa, L. B. (2026). Assessing Primary Aldosteronism Screening Implementation and Interpretation in an Outpatient Internal Medicine Clinic: A Cohort Study. AACE Endocrinology and Diabetes, 13(3), 527-532. https://doi.org/10.1016/j.aed.2026.01.017
Vancouver
Allen RB, Hui T, Tungate Lopez S, Komé AM, Yang A, Zink L, et al. Assessing Primary Aldosteronism Screening Implementation and Interpretation in an Outpatient Internal Medicine Clinic: A Cohort Study. AACE Endocrinology and Diabetes. 2026;13(3):527-532. doi:10.1016/j.aed.2026.01.017
BibTeX
@article{Allen2026,
author = {Allen, Rachel B and Hui, Thomas and Tungate Lopez, Shelby and Komé, Anne M and Yang, Anita and Zink, Lindsay and Espinosa, Luis Borges},
title = {Assessing Primary Aldosteronism Screening Implementation and Interpretation in an Outpatient Internal Medicine Clinic: A Cohort Study},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
volume = {13},
number = {3},
pages = {527--532},
doi = {10.1016/j.aed.2026.01.017}
}
EUVIMED